Neuronetics Shines at Clinical TMS Meeting with NeuroStar Data

Neuronetics Inc. (NASDAQ:STIM) is a top-performing NASDAQ stock. At the Clinical TMS Society/CTMSS Meeting, NeuroStar showcased data from the TrakStar database, including TMS outcomes in elderly adults and a comparison of treatment outcomes between NeuroStar’s Figure-8 coil and Brainsway’s H-coil for depression.

NeuroStar participated in the PULSES Course and shared updates on Greenbrook Mental Wellness Centers’ Personalized Care Trial Program. Neuronetics offers office treatments for neurohealth disorders. While STIM shows investment potential, other AI stocks may offer greater upside with less risk. Explore the best short-term AI stock for potential growth.

Read more at Yahoo Finance: Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting